Clinical Trial Update: Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating omega-3 fatty acids for colorectal cancer prevention in patients with Lynch syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lynch Syndrome

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Colorectal Cancer, Lynch Syndrome | Phase 2 | Status: UNKNOWN